LONDON, April 22, 2025 /PRNewswire/ -- This April, Azazie, the global leader in online bridalwear, made an unforgettable impression at The National Wedding Show at ExCeL London. Located at Stand D70, the brand unveiled its most expansive UK presentation to date—a thoughtfully curated bridalwear collection celebrating inclusivity, modern romance, and personal expression. The showcase offered attendees an exclusive first look at Azazie's highly anticipated London Pop-Up, alongside a glimpse into the wedding trends set to define 2025.
Breaking Tradition, Embracing Individuality
Azazie redefined what bridal looks like in 2025. Across six high-energy catwalk shows, the brand debuted everything from sweeping fairytale gowns to clean-cut modern silhouettes, tailored bridal pantsuits, and bridesmaid dresses in vibrant hues. This season's focus? Celebrating self-expression. Every look was designed with today's bride in mind.
The Pop-Up Everyone's Talking About
Visitors were given an exclusive first look—and first access—to Azazie's 2-Day London Pop-Up, happening April 19–20. With over 750 garments available to try on, it's the largest single-location preview Azazie has ever hosted in the UK. Highlights include:
- 500+ Bridesmaid Dresses in 80+ colours and sizes 4–34
- 150 Wedding Dresses ranging from timeless lace to daring fashion-forward cuts
- 25 Flower Girl Dresses
- 25 Junior Bridesmaid Looks
- 25 Mother-of-the-Bride Dresses
- 25 Occasionwear Styles, perfect for black-tie guests or second looks
With just a quick QR scan, brides secured their personalised fitting appointments—complete with expert stylists and on-the-spot advice for curating their wedding wardrobe with ease.
Not Just a Booth—An Experience
Azazie went beyond the typical vendor setup and built an immersive showroom-style space, where guests could slip into gowns, explore fabric swatches, and chat directly with the team about fit, customisation, and the perks of Azazie's seamless online shopping experience.
Fan-favourite Spin-to-Win returned, offering prizes like stretch satin scrunchies, wedding garters, jewellery boxes, and 10% off vouchers—adding a little extra sparkle to every visit.
Expanding Its Footprint in the UK
Following a successful showing in Birmingham, Azazie's London debut drew thousands of visitors, including entire bridal parties discovering the brand's affordable, size-inclusive, made-to-order model for the very first time.
With a growing UK presence and increasing demand, Azazie is solidifying its role as the go-to destination for modern brides who want standout style without the boutique markup.
Ready to Say Yes?
To learn more about Azazie's full UK offering or to book your spot at the upcoming London Pop-Up, visit www.azazie.com.
ABOUT AZAZIE
Azazie is the leading direct-to-consumer (DTC) e-tailer, providing an array of bridal gowns, bridesmaid dresses, evening wear, and accessories. Designed in Los Angeles, Azazie disrupts the traditional wedding industry by offering made-to-order gowns at an affordable price point. The brand is dedicated to promoting body-positive fashion, ensuring that all dresses—available in sizes 0-30—are meticulously cut and sewn to order. Explore our website to discover hundreds of bridal and bridesmaid gowns and dresses in over 80+ stunning color options.
Media Contact:
pr@azazie.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Azazie Makes a Statement at London's National Wedding Show with Bold Bridal Looks and the UK's Largest Pop-Up Experience
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
